Education
About Us
Working with TipRanks
Follow Us
Collegium Pharmaceutical (COLL)
NASDAQ:COLL
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 780.57M | $ 631.45M | $ 566.77M | $ 463.93M | $ 276.87M |
| Gross Profit | $ 463.26M | $ 377.34M | $ 326.17M | $ 209.49M | $ 150.62M |
| Operating Income | $ 187.08M | $ 169.90M | $ 166.96M | $ 33.32M | $ 17.63M |
| EBITDA | $ 401.00M | $ 341.70M | $ 308.33M | $ 173.31M | $ 86.56M |
| Net Income | $ 62.87M | $ 69.19M | $ 48.16M | $ -25.00M | $ 71.52M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 406.53M | $ 162.76M | $ 310.55M | $ 173.69M | $ 186.43M |
| Total Assets | $ 1.66B | $ 1.66B | $ 1.14B | $ 1.17B | $ 692.08M |
| Total Debt | $ 940.56M | $ 859.30M | $ 674.28M | $ 709.17M | $ 258.75M |
| Net Debt | $ 689.46M | $ 788.73M | $ 435.34M | $ 535.49M | $ 72.32M |
| Total Liabilities | $ 1.36B | $ 1.43B | $ 947.88M | $ 979.29M | $ 489.15M |
| Stockholders' Equity | $ 301.68M | $ 228.84M | $ 195.43M | $ 194.84M | $ 202.93M |
| Cash Flow | |||||
| Free Cash Flow | $ 327.58M | $ 203.33M | $ 274.29M | $ 122.61M | $ 101.61M |
| Operating Cash Flow | $ 329.32M | $ 204.98M | $ 274.75M | $ 124.23M | $ 103.56M |
| Investing Cash Flow | $ -63.53M | $ -287.76M | $ -70.81M | $ -573.69M | $ -1.94M |
| Financing Cash Flow | $ -110.25M | $ -60.60M | $ -140.18M | $ 436.72M | $ -89.30M |